130 related articles for article (PubMed ID: 26886076)
1. Differentiating Between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging.
Motiei M; Dreifuss T; Betzer O; Panet H; Popovtzer A; Santana J; Abourbeh G; Mishani E; Popovtzer R
ACS Nano; 2016 Mar; 10(3):3469-77. PubMed ID: 26886076
[TBL] [Abstract][Full Text] [Related]
2. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
3. Uptake mechanism of metabolic-targeted gold nanoparticles.
Dreifuss T; Ben-Gal TS; Shamalov K; Weiss A; Jacob A; Sadan T; Motiei M; Popovtzer R
Nanomedicine (Lond); 2018 Jul; 13(13):1535-1549. PubMed ID: 30028251
[TBL] [Abstract][Full Text] [Related]
4. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY
Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011
[TBL] [Abstract][Full Text] [Related]
5. Quantitative imaging of gold nanoparticle distribution in a tumor-bearing mouse using benchtop x-ray fluorescence computed tomography.
Manohar N; Reynoso FJ; Diagaradjane P; Krishnan S; Cho SH
Sci Rep; 2016 Feb; 6():22079. PubMed ID: 26912068
[TBL] [Abstract][Full Text] [Related]
6. PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer.
Basu S; Kumar R; Alavi A
Indian J Cancer; 2010; 47(4):371-9. PubMed ID: 21131748
[TBL] [Abstract][Full Text] [Related]
7. A novel functional CT contrast agent for molecular imaging of cancer.
Li J; Chaudhary A; Chmura SJ; Pelizzari C; Rajh T; Wietholt C; Kurtoglu M; Aydogan B
Phys Med Biol; 2010 Aug; 55(15):4389-97. PubMed ID: 20647599
[TBL] [Abstract][Full Text] [Related]
8. Imaging of tumor glucose utilization with positron emission tomography.
Buerkle A; Weber WA
Cancer Metastasis Rev; 2008 Dec; 27(4):545-54. PubMed ID: 18523732
[TBL] [Abstract][Full Text] [Related]
9. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
10. Facile formation of dendrimer-stabilized gold nanoparticles modified with diatrizoic acid for enhanced computed tomography imaging applications.
Peng C; Li K; Cao X; Xiao T; Hou W; Zheng L; Guo R; Shen M; Zhang G; Shi X
Nanoscale; 2012 Nov; 4(21):6768-78. PubMed ID: 23010987
[TBL] [Abstract][Full Text] [Related]
11. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
13. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
[TBL] [Abstract][Full Text] [Related]
14. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
15. Gold Nanoparticle-Based Fluorescent Contrast Agent with Enhanced Sensitivity.
Kang KA; Nguyen MD
Adv Exp Med Biol; 2017; 977():399-407. PubMed ID: 28685471
[TBL] [Abstract][Full Text] [Related]
16. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
Kim D; Park S; Lee JH; Jeong YY; Jon S
J Am Chem Soc; 2007 Jun; 129(24):7661-5. PubMed ID: 17530850
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of PEGylated low generation dendrimer-entrapped gold nanoparticles for CT imaging applications.
Liu H; Wang H; Xu Y; Shen M; Zhao J; Zhang G; Shi X
Nanoscale; 2014 May; 6(9):4521-6. PubMed ID: 24647803
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging.
Meir R; Shamalov K; Betzer O; Motiei M; Horovitz-Fried M; Yehuda R; Popovtzer A; Popovtzer R; Cohen CJ
ACS Nano; 2015 Jun; 9(6):6363-72. PubMed ID: 26039633
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles allow detection of early-stage edema in mice via computed tomography imaging.
Domey J; Teichgräber U; Hilger I
Int J Nanomedicine; 2015; 10():3803-14. PubMed ID: 26082631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
